CALLE DOCTOR FLEMING, 51 | 28036 MADRID, SPAIN
+34 91 3459395 | +44 (0) 20 3951 8071
info@oxonepi.com

White Paper RWE needs in Oncology: Breast Cancer

White-Paper-Breast-Cancer

REAL WORLD EVIDENCE NEEDS IN ONCOLOGY:
Breast Cancer

White Paper based on new trial results from ESMO Congress, 20-24 October 2023, Madrid.

Metastatic breast cancer continues to be a significant health challenge in oncology. As the most common cancer in women worldwide, it imposes substantial healthcare burdens and necessitates continuous research and innovation in treatment strategies.

OXON has analyzed the results of the trials presented at ESMO 2023, and examined their potential impact on current clinical guidelines and practices in breast cancer treatment to help guide the RWE gaps by addressing breakthroughs and challenges in treatments across different metastatic breast cancer subtypes.

To download the white paper please complete the following form:

    Your details: Fields marked with an asterisk (*) are required.

    First Name*

    Last Name*

    Work Email address*

    Company*

    Department*

    Position*

    Country*

    As responsible for the processing of the personal data you provide, OXON informs you that your data will be processed in accordance with the provisions of the laws in force related to data protection and notably the General Data Protection Regulation 2016/679. Your data will be used to establish or maintain a business relationship and sending you communications about our services. The data will be kept as long as there is a legitimate interest. As a data subject, you will have the right to withdraw your consent at any time. You will also have the right to access, to rectify, to erase your personal data as well as the right to ask for its portability or the limitation of its processing.